GLP-1R reporter cell line for diabetes / obesity research
June 27, 2024
AMSBIO has launched a Glucagon-Like Peptide 1 Receptor (GLP-1R) reporter cell line. GLP-1R is known to play a key role in controlling blood sugar levels by enhancing glucose-stimulated insulin secretion. Therefore, there is considerable interest in harnessing regulation of the GLP-1R mediated signaling pathway as a therapeutic approach to type 2 diabetes which has already resulted [...]
EditCo Bio, Inc. Expands Primary Cell Portfolio with Launch of Knockout CD8+ T-cell Pools
June 27, 2024
Enhancing Immunotherapy and Cancer Research with Advanced CRISPR-Mediated Gene Editing REDWOOD CITY, Calif. -- EditCo Bio, Inc., a leader in genome engineering innovation, announced the expansion of its T-cell editing portfolio with the launch of Knockout CD8+ T-cell Pools. This new addition builds upon the success of their Knockout CD4+ T-cell Pools, offering researchers an advanced [...]
PAIR DISTRIBUTION FUNCTION XRD INSTALLED AT UFABC / SAO PAULO
June 27, 2024
The Laboratório de Cristalografia e Caracterização Estrutural de Materiais (LCCEM), under the management of Prof. Fabio Furlan Ferreira at the Federal University of ABC (UFABC), Brazil, has enhanced its already excellent facilities for powder X-ray diffraction (PXRD). The laboratory, known for its structural characterization of crystalline, nanocrystalline, and amorphous materials at room temperature and for in [...]
Pierre-Alain Ruffieux joins Cytiva as Chief Operating Officer
June 27, 2024
Renowned, experienced industry leader in newly created role for Cytiva Ruffieux joins Cytiva executive team on 1 July 2024 Cytiva is strengthening its leadership team with one of the biotechnology industry’s most highly regarded and experienced leaders, Pierre-Alain Ruffieux, who will join as Chief Operating Officer. Ruffieux will come onboard 1 July. He will be [...]
June 27, 2024
The Nio Lineup Now Consists of 3 Instruments: the accessible Nio™ E configuration provides the essence of Crystal Digital™ PCR to all labs, the Nio™ is a flexible mid-level instrument and the Nio™+ remains the flagship of the Nio family Nio™+ is recognized for exceptional design and innovation with the renowned reddot design award.[RD1] Paris and [...]
Elemental Machines Expands European Presence and Enhances AI-Predicted Health Score
June 27, 2024
FLORENCE, Italy – Elemental Machines, a leader in smart lab and manufacturing connectivity solutions, is pleased to announce they are consolidating their position in the EU by establishing a legal entity: Elemental Machines SRL. This strategic move reinforces the company’s commitment to serving the global life sciences industry. The European office in Italy has been operational [...]
June 27, 2024
Seattle, WA – RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company providing advanced Precision Biology platforms including instruments, reagents, software, and services announced today the completion of a $20M financing from new and existing investors. The funding is expected to enable the Company to drive an expansion of the successful Orion Spatial Biology [...]
June 27, 2024
Fremont, CA – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease in collaboration with the Biomarkers of Aging Consortium, a consortium dedicated to the development and validation of biomarkers of aging and longevity, announced today the launch of the next phase of the Biomarkers of Aging Challenge Series. This [...]
ArcticZymes Technologies Confirms New Board of Directors Following Annual General Meeting Approval
June 27, 2024
Tromsø, Norway – ArcticZymes Technologies ASA (OSE: AZT) is pleased to announce the successful approval of its new Board of Directors at the recent Annual General Meeting. This marks a significant milestone for the company, as we welcome a diverse and accomplished group of leaders poised to guide ArcticZymes towards a future of continued innovation and [...]
Genetic Sequence Data Analysis & Reporting Accelerated with Velsera’s Release of CGW Plus
June 27, 2024
Guiding Biomarker Quality and Evidence Reviews Transform Clinical Genomics BOSTON -- Velsera, a leading global healthcare technology company offering a universal software platform to connect clinical care with discovery, is thrilled to announce the launch of CGW Plus, its reimagined Clinical Genomics Workspace (CGW) platform. This update introduces advanced variant quality and clinical evidence review [...]

